Form 4: Eli Lilly Executive Anne E. White Reports Stock Transactions

Anne E. White, EVP & President of Lilly Neuroscience, reported the acquisition of 4,124 shares of Eli Lilly common stock through restricted stock units and the disposition of 1,844 shares to cover tax obligations.

Summary

• Anne E. White, an Executive Vice President at Eli Lilly, reported transactions involving the company's common stock on February 1, 2024.
• She acquired 4,124 shares through the vesting of restricted stock units at no cost.
• Additionally, she disposed of 1,844 shares to cover tax obligations at a price of $645.61 per share.
• Following these transactions, Ms. White directly owns 60,206 shares of Eli Lilly common stock.

Sentiment

Score: 6

Explanation: The document reflects routine executive stock transactions, which are neither particularly positive nor negative. The sentiment is neutral.

Positives

• The acquisition of shares through restricted stock units indicates a form of compensation and alignment with the company's performance.
• The vesting of restricted stock units is a common practice for executive compensation.

Negatives

• The sale of shares to cover tax obligations reduces the total number of shares held by the executive.

Risks

• Executive stock transactions can sometimes be interpreted as a signal of the executive's sentiment about the company's future performance, although this transaction appears to be routine.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often part of their compensation packages. These transactions are closely monitored by investors for insights into executive sentiment and potential future performance.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time, similar to the transaction reported by Anne E. White.
• The sale of shares to cover tax obligations is a standard practice among executives who receive equity compensation.
• Other pharmaceutical companies such as Pfizer (PFE) and Johnson & Johnson (JNJ) also have executives who regularly report similar transactions.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.

Key Dates

Keywords

Eli Lilly, LLY, stock transaction, restricted stock units, executive compensation, Form 4, insider trading, Anne E. White